Effect of Eranda Beeja Arka and Vatari Guggulu In Gridhrasi (Sciatica)

A Comparative Clinical Study To Evaluate The Add On Effect Of Eranda Beeja Arka In The Management Of Gridhrasi w.s.r. To Sciatica - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070756

Enrollment

Registered

2024-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects with classical signs and symptoms of Gridhrasi and Sciatica will be selected. 20-60 years will be selected. 2.Subjects of irrespective gender and age between 3.Patients with Positive SLR Test will be selected.

Exclusion criteria

Exclusion criteria: 1.Patients who are already diagnosed with the following diseases will be excluded from the study a)Spinal Deformity, Spinal Tumors, Spinal TB and Carcinoma of the Spine. b)Severe Traumatic Injury. c)Viral Infection like Poliomyelitis. d)Congenital abnormalities in spine. e)Severe cases with surgical indication. 2.Other systemic diseases which interferes with the intervention of this study.

Design outcomes

Primary

Measure	Time frame
Effect of trial drug on improvements in the symptoms of Gridhrasi(Sciatica)Timepoint: 7Day,14Day,21Day	—

Secondary

Measure	Time frame
Safety of trial drug and Adverse Drug Reaction and Aggravation of Symptoms of Gridhrasi(Sciatica)Timepoint: 7Day,14Day,21Day	—

Countries

India

Contacts

Public ContactDr Prasuna

Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre

drmsb123@rediffmail.com9036701207

Outcome results